CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Live Science on MSN3d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback